Zdrowie i gospodarka · 01/06/1998

FDA Announces Draft Guidance for Electronic Submissions of Biologics License Applications

The FDA has released a draft guidance document outlining the process for electronic submissions of Biologics License Applications (BLAs) and Product License Applications (PLAs) to the Center for Biologics Evaluation and Research (CBER), with the goal of improving efficiency in the regulatory review process for biological products.